Molecular study on genital wart patients in Babylon province-Iraq



American Journal of BioMedicine  Volume 2, Issue 10, pages 1119-1126 October 2014

Israa Abbas Mahdi Al Saadi; Mohammed A.K. Al Saadi; Wisam A.A. Ewadh


The aim of this study was to molecular identification of HPV genotypes in genital wart patients in their blood samples in Babylon province-Iraq. This work was applied on (40) genital wart patients admitted to the outpatient department of Dermatology and Venereology in Merjan Medical City, Hilla-Iraq and private clinic during the period from November (2013) to March (2014). The patients consist of (16 males and 24 females) with their age range (2-48) years, while (20) apparently health controls which consist of (males and females) with age range approximately matched to genital wart patients. Blood samples were collected from both patients and controls to identify the genotypes of HPV by molecular methods by polymerase chain reaction (PCR). The results of this study showed (15%) positive for HPV genotypes. The positive results of HPV genotypes were (high risk group) for this virus.

Keywords: HPV; Genital wart; Polymerase chain reaction; Molecular methods

Open Access              Full Text-PDF                Feedback


1. Kiprono SJ,  Erick A, Titus SK. Knowledge, Attitude and Practices of Students Enrolled in Health Related Courses at Saint Louis University towards Human Papillomavirus (Philippines). Journal of Natural Sciences Rese 2012; 2(6): 48-54. [Abstarct/Full-Text PDF]

2. Pirog E.  Molecular markers and HPV detection in the diagnosis of lower genital tract lesions. PhD thesis. De. Vrije Universities Amsterdam 2011. [Abstarct/Full-Text PDF]

3. zur Hausen H. Papillomaviruses in the causation of human cancers – a brief historical account. Virology 2009;384(2):260-5. [PubMed]

4. American Cancer Society. (2013). Human papilloma virus (HPV), Cancer, HPV testing, and HPV vaccines: Frequently asked questions. [Website]

5. Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiency. J. Allergy. Clin. Immunology 2012;130: 1030-48. [PubMed]

6. CDC .Genital HPV Infection 2013. [Website]

7. Bain B, Bates I, Laffan M, S. Lewis. Dacie and Lewis Practical Haematology, 11th Edition. 2012, Churchill Livingstone, London. [Publisher]

8. Che -Ha Chen A, Keleher A, Mary-Anne K, et al. Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. Prostate Cancer Foundation in Australia. [Abstract/Full-Text]

9. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000;74(24):11636-41. [PubMed]

10. Chen AC1, McMillan NA, Antonsson A. Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure. J Gen Virol 2008;89(Pt 11):2891-7. [PubMed]

11. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118(12):3030-44. [PubMed]

12. Bodaghi S1, Wood LV, Roby G, et al. Could human papillomaviruses be spread through blood? J Clin Microbiol 2005;43(11):5428-34. [PubMed]

13. Gearhart PA. Human Papillomavirus, 2012 Medscape. [Website]

14. Syrjänen S. Current concepts on human papillomavirus infections in children. APMIS. 2010;118(6-7):494-509. [PubMed]

15. KKaye JN1, Cason J, Pakarian FB, et al. Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child. J Med Virol 1994;44(4):415-21. [PubMed]

16. Smith EM1, Johnson SR, Cripe T, et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev 1995;19(2):196-205. [PubMed]

17. Roden RB1, Kirnbauer R, Jenson AB, Lowy DR, Schiller JT. Interaction of papillomaviruses with the cell surface. J Virol 1994;68(11):7260-6. [PubMed]

18. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 1997;71(3):2449-56. [PubMed]

19. Wang SS, Hildesheim A. Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr. 2003;(31):35-40. [PubMed]

20. Drobni P, Mistry N, McMillan N, Evander M. Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry.

Virology 2003;310(1):163-72. [PubMed]

21. Pao CC, Lin SS, Lin CY, Maa JS, Lai CH, Hsieh TT. Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol 1991;95(4):540-6. [PubMed]

22. Burns T,  Breathnach S, Cox N,  Griffiths C. (2010). Rook’s Text book of Dermatology. Volum1 8th ed. Wiley-Blackwell. U.K. [Publisher]

23. Liaw KL1, Glass AG, Manos MM, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999;91(11):954-60. [PubMed]

24. Woodman CB1, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357(9271):1831-6. [PubMed]

25. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297(8):813-9. [PubMed]

26. Banura C. Human papillomavirus infections among sexually active young women in Uganda: Implications for a vaccination strategy. PhD thesis. 2009 Makerere University. [Full-Text PDF]

27. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415-23. [PubMed]

28. Wheeler CM. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstet Gynecol Clin North Am. 2008;35(4):519-36; vii. [PubMed]

Print Friendly, PDF & Email